firstwordpharmaJuly 13, 2021
Tag: Covaxin , COVID-19 vaccine , WHO
Bharat Biotech on Monday said it has submitted all documents required for the emergency use listing of its COVID-19 vaccine Covaxin to the World Health Organization (WHO), as reported by The Economic Times.
Last week, WHO chief scientist Soumya Swaminathan said the agency is likely to take a decision on Covaxin’s emergency use listing within four to six weeks.
"All documents required for Emergency Use Listing (EUL) of Covaxin have been submitted to WHO as of 9th July. The review process has now commenced with the expectation that we will receive EUL from WHO at the earliest," tweeted Bharat chairman Krishna Ella.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: